Перейти к основному содержанию
AkademIndex

Продукты

Для разработчиков

AkademBaseОткрытый API экосистемы
← Назад к работе

Работы, на которые ссылается эта работа

Работ: 56

Работа: Dihydromyricetin: A potential candidate for the treatment of cholestatic liver injury via inhibition of the NLRP3 inflammasome

  1. Dihydromyricetin Prevents Diabetic Cardiomyopathy via miR-34a Suppression by Activating Autophagy

    Tingjuan Ni, Na Lin, Wenqiang Lu +4

    Статья2020Цитирований: 3
    ABI

  2. Dihydromyricetin Protects the Liver via Changes in Lipid Metabolism and Enhanced Ethanol Metabolism

    Joshua Silva, Xin Yu, Renita Moradian +6

    Статья2020Цитирований: 3
    ABI

  3. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death

    Jianjin Shi, Yue Zhao, Kun Wang +7

    Статья2015Цитирований: 3
    ABI

  4. Mechanisms of hepatic stellate cell activation

    Takuma Tsuchida, Scott L. Friedman

    Обзорная статья2017Цитирований: 3
    ABI

  5. Mechanisms of action and therapeutic efficacy of ursodeoxycholic acid in cholestatic liver disease

    G. Paumgartner, Ulrich Beuers

    Обзорная статья2004Цитирований: 2
    ABI

  6. Dihydromyricetin: A review on identification and quantification methods, biological activities, chemical stability, metabolism and approaches to enhance its bioavailability

    Dan Liu, Yiqin Mao, Lijun Ding +1

    Обзорная статья2019Цитирований: 2
    ABI

  7. Dihydromyricetin alleviates doxorubicin-induced cardiotoxicity by inhibiting NLRP3 inflammasome through activation of SIRT1

    Zhenzhu Sun, Wenqiang Lu, Na Lin +6

    Статья2020Цитирований: 2
    ABI

  8. Dihydromyricetin increases endothelial nitric oxide production and inhibits atherosclerosis through microRNA‐21 in apolipoprotein E‐deficient mice

    Dafeng Yang, Zhousheng Yang, Lei Chen +15

    Статья2020Цитирований: 2
    ABI

  9. Dihydromyricetin ameliorates chronic liver injury by reducing pyroptosis

    Quancheng Cheng, Jing Fan, Xin-Wei Deng +6

    Статья2020Цитирований: 2
    ABI

  10. Dihydromyricetin improves DSS-induced colitis in mice via modulation of fecal-bacteria-related bile acid metabolism

    Sijing Dong, Min Zhu, Ke Wang +5

    Статья2021Цитирований: 2
    ABI

  11. Dihydromyricetin alleviates Escherichia coli lipopolysaccharide-induced hepatic injury in chickens by inhibiting the NLRP3 inflammasome

    Chenxi Shi, Jiaqi Wang, Ruichen Zhang +7

    Статья2022Цитирований: 2
    ABI

  12. Dihydromyricetin prevents obesity <i>via</i> regulating bile acid metabolism associated with the farnesoid X receptor in <i>ob</i>/<i>ob</i> mice

    Yanjun Song, Le Sun, Pei Ma +2

    Статья2022Цитирований: 2
    ABI

  13. Dihydromyricetin protects against Doxorubicin-induced cardiotoxicity through activation of AMPK/mTOR pathway

    Xiaoqi Li, Xin Wang, Binyu Wang +7

    Статья2022Цитирований: 2
    ABI

  14. Molecular mechanism and therapeutic significance of dihydromyricetin in nonalcoholic fatty liver disease

    Hang Gong, Huimei Xu, Muyang Li +1

    Обзорная статья2022Цитирований: 2
    ABI

  15. Dihydromyricetin attenuates cisplatin-induced acute kidney injury by reducing oxidative stress, inflammation and ferroptosis

    Zheming Xu, Minjing Zhang, Wenwen Wang +19

    Статья2023Цитирований: 2
    ABI

  16. Preparation, characterization and protective effect of chitosan - Tripolyphosphate encapsulated dihydromyricetin nanoparticles on acute kidney injury caused by cisplatin

    Qiaohua Yan, Meiqing Li, Liying Dong +12

    Статья2023Цитирований: 2
    ABI

  17. Modulation of keap-1/Nrf2/HO-1 and NF-ĸb/caspase-3 signaling pathways by dihydromyricetin ameliorates sodium valproate-induced liver injury

    Doaa Emad, Asmaa M. A. Bayoumi, Sahar M. Gebril +2

    Статья2024Цитирований: 2
    ABI

  18. A role for mitochondria in NLRP3 inflammasome activation

    Rongbin Zhou, Amir S. Yazdi, Philippe Menu +1

    Статья2010Цитирований: 2
    ABI

  19. MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition

    Rebecca C. Coll, James R. Hill, Christopher J. Day +8

    Статья2019Цитирований: 2
    ABI

  20. Pyroptosis and Apoptosis Pathways Engage in Bidirectional Crosstalk in Monocytes and Macrophages

    Cornelius Y. Taabazuing, Marian C. Okondo, Daniel A. Bachovchin

    Статья2017Цитирований: 2
    ABI

  21. Estrogen accelerates the resolution of inflammation in macrophagic cells

    Alessandro Villa, Nicoletta Rizzi, Elisabetta Vegeto +2

    Статья2015Цитирований: 2
    ABI

  22. Sex differences in immune responses

    Sabra L. Klein, Katie L. Flanagan

    Обзорная статья2016Цитирований: 2
    ABI

  23. Dihydromyricetin regulates the miR-155-5p/SIRT1/VDAC1 pathway to promote liver regeneration and improve alcohol-induced liver injury

    Qing Ma, Shuo Huang, Mei-ya Li +13

    Статья2025Цитирований: 2
    ABI

  24. Без названия

    ДругоеЦитирований: 1
    ABI

  25. Без названия

    ДругоеЦитирований: 1
    ABI